1. Hunt, N. J., Kang, S. W. S., Lockwood, G. P., Le Couteur, D. G. & Cogger, V. C. Hallmarks of aging in the liver. Computational and structural biotechnology journal 17, 1151–1161 (2019).
2. Barbosa, M. C., Grosso, R. A. & Fader, C. M. Hallmarks of aging: an autophagic perspective. Frontiers in endocrinology 9, 790 (2019).
3. Chakravarti, D., LaBella, K. A. & DePinho, R. A. Telomeres: history, health, and hallmarks of aging. Cell (2021).
4. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
5. Chung, H. Y. et al. Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept. Aging and disease 10, 367 (2019).
6. Duggal, N. A., Niemiro, G., Harridge, S. D., Simpson, R. J. & Lord, J. M. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nature Reviews Immunology 19, 563–572 (2019).
7. Aiello, A. et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Frontiers in immunology 10, 2247 (2019).
8. Fulop, T. et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Frontiers in immunology 8, 1960 (2018).
9. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. science 284, 143–147 (1999).
10. Meirelles, L. da S., Chagastelles, P. C. & Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of cell science 119, 2204–2213 (2006).
11. Wang, J. et al. Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine. Tissue and cell 64, 101330 (2020).
12. da Silva Meirelles, L., Caplan, A. I. & Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem cells 26, 2287–2299 (2008).
13. Yang, Y.-H. K., Ogando, C. R., See, C. W., Chang, T.-Y. & Barabino, G. A. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem cell research & therapy 9, 1–14 (2018).
14. Yang, Y.-H. K. Aging of mesenchymal stem cells: Implication in regenerative medicine. Regenerative therapy 9, 120–122 (2018).
15. Lau, A., Kennedy, B. K., Kirkland, J. L. & Tullius, S. G. Mixing old and young: enhancing rejuvenation and accelerating aging. The Journal of clinical investigation 129, 4–11 (2019).
16. Shen, J. et al. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Scientific reports 1, 1–7 (2011).
17. Cao, N. et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells reverse cognitive aging via improving synaptic plasticity and endogenous neurogenesis. Cell death & disease 8, e2996–e2996 (2017).
18. Fu, Y. et al. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Engineering Part B: Reviews 23, 515–528 (2017).
19. Yuan, Q., Zhang, Y. & Chen, Q. Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine. The Anatomical Record 303, 1735–1742 (2020).
20. Wagner, W. et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem cells 25, 2638–2647 (2007).
21. Meng, X. et al. Comparative analysis of microRNA expression in human mesenchymal stem cells from umbilical cord and cord blood. Genomics 107, 124–131 (2016).
22. Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature reviews immunology 8, 523–532 (2008).
23. Georgiev, P., Charbonnier, L.-M. & Chatila, T. A. Regulatory T cells: the many faces of Foxp3. Journal of clinical immunology 39, 623–640 (2019).
24. Arroyo Hornero, R., Hamad, I., Côrte-Real, B. & Kleinewietfeld, M. The Impact of Dietary Components on Regulatory T Cells and Disease. Frontiers in immunology 11, 253 (2020).
25. Hahn, H. J., Kim, K. B., An, I.-S., Ahn, K. J. & Han, H. J. Protective effects of rosmarinic acid against hydrogen peroxide‑induced cellular senescence and the inflammatory response in normal human dermal fibroblasts. Molecular medicine reports 16, 9763–9769 (2017).
26. Huang, Y.-H., Wu, P.-Y., Wen, K.-C., Lin, C.-Y. & Chiang, H.-M. Protective effects and mechanisms of Terminalia catappa L. methenolic extract on hydrogen-peroxide-induced oxidative stress in human skin fibroblasts. BMC complementary and alternative medicine 18, 1–9 (2018).
27. Sui, B.-D. et al. Stem cell-based bone regeneration in diseased microenvironments: challenges and solutions. Biomaterials 196, 18–30 (2019).
28. Asumda, F. Z. Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging. Stem cell research & therapy 4, 1–11 (2013).
29. Kuhn, N. Z. & Tuan, R. S. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. Journal of cellular physiology 222, 268–277 (2010).
30. Le Garff-Tavernier, M. et al. Human NK cells display major phenotypic and functional changes over the life span. Aging cell 9, 527–535 (2010).
31. Huang, H., Patel, D. D. & Manton, K. G. The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 10, 192–215 (2005).
32. Camous, X., Pera, A., Solana, R. & Larbi, A. NK cells in healthy aging and age-associated diseases. Journal of Biomedicine and Biotechnology 2012, (2012).
33. Solana, R., Campos, C., Pera, A. & Tarazona, R. Shaping of NK cell subsets by aging. Current opinion in immunology 29, 56–61 (2014).
34. Müller, L., Di Benedetto, S. & Pawelec, G. The immune system and its dysregulation with aging. Biochemistry and Cell Biology of Ageing: Part II Clinical Science 21–43 (2019).
35. Zhang, H., Puleston, D. J. & Simon, A. K. Autophagy and immune senescence. Trends in molecular medicine 22, 671–686 (2016).
36. Salminen, A. Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. Journal of Molecular Medicine 1–20 (2020).
37. Madelung, C. F., Falk, M. K. & Sørensen, T. L. The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood. Clinical Ophthalmology (Auckland, NZ) 9, 1147 (2015).
38. Gliwiński, M., Piotrowska, M., Iwaszkiewicz-Grześ, D., Urban-Wójciuk, Z. & Trzonkowski, P. Therapy with CD4 + CD25 + T regulatory cells–should we be afraid of cancer? Contemporary Oncology 23, 1 (2019).
39. Lynch, H. E. et al. Thymic involution and immune reconstitution. Trends in immunology 30, 366–373 (2009).
40. Gasek, N. S., Kuchel, G. A., Kirkland, J. L. & Xu, M. Strategies for targeting senescent cells in human disease. Nature Aging 1, 870–879 (2021).
41. Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nature communications 9, 1–15 (2018).
42. Di Marzo, N., Chisci, E. & Giovannoni, R. The role of hydrogen peroxide in redox-dependent signaling: homeostatic and pathological responses in mammalian cells. Cells 7, 156 (2018).